---

Cardinal Health to Brief Investors on New Initiatives at Pyxis Subsidiary

Company Also Expects to Meet Analysts' Estimates for Fiscal 2002 First Quarter

DUBLIN, Ohio, Oct 9, 2001 /PRNewswire via COMTEX/ -- Cardinal Health, Inc. (NYSE: CAH) said it will brief investors tomorrow on several new initiatives at its Pyxis Corporation subsidiary during an online presentation and conference call beginning at 8:30 a.m. Eastern Time.

Cardinal Health also said it expects to meet analysts' consensus estimates for net earnings of 55 cents per diluted common share for its fiscal 2002 first quarter ending September 30, 2001. The company reiterated its previous guidance for earnings per share growth of between 20 and 22 percent for the fiscal year ending June 30, 2002. Both the quarterly and annual estimates for fiscal 2002 exclude special charges, as well as goodwill amortization in accordance with the company's adoption of Statement of Financial Accounting Standards No. 142.

Tomorrow's presentation will focus on Pyxis' history of growth and a number of changes its management is putting in place to better manage and sustain that growth. The outcome of these changes will be more efficient operations, enhanced services for customers and greater visibility for investors into Pyxis' business processes and expanding pipeline of sales.

Pyxis is the leading manufacturer and marketer of a broad range of automated systems that store and dispense medications and medical supplies at hospitals, nursing homes and other sites of care. With more than 90,000 systems installed, Pyxis helps hospitals and other institutions more effectively manage costs and improve patient safety.

To access the online presentation, investors should visit http://www.cardinal.com and follow prompts to Cardinal Health's Investor Center. Investors also can call 1-212-346-7459. The replay of the call will be available at http://www.cardinal.com and at 1-800-633-8284, with the passcode of 19841134. The replay will be available until 10:30 a.m. on October 13, 2001.

Cardinal Health, Inc. ( http://www.cardinal.com ) is a leading provider of products and services supporting the health-care industry. Cardinal Health companies develop, manufacture, package and market products for patient care; develop drug-delivery technologies; distribute pharmaceuticals, medical- surgical and laboratory supplies; and offer consulting and other services that improve quality and efficiency in health care. The company, which is headquartered in Dublin, Ohio, employs more than 49,000 people on five continents and produces annual revenues of more than $40 billion. More information about Pyxis and its products can be found at http://www.pyxis.com .

Except for historical information, all other information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking information and statements in this news release are subject to various risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. These risks and uncertainties include but are not limited to: those discussed or identified in the public filings with the U.S. Securities and Exchange Commission (SEC) made by Cardinal Health; risks and uncertainties with respect to Cardinal Health's expectations regarding the accounting and tax treatment of acquisitions, the value of merger consideration, growth opportunities, earnings accretion, cost savings, revenue enhancements, synergies and other benefits anticipated from acquisition transactions; the costs and effects of government regulation and legal and administrative proceedings; difficulties related to integrating acquired businesses; the effect of any changes in customer and supplier relationships and customer purchasing patterns, shifts in the growth rates among segments driven by various factors, general consumer perceptions of health-related concerns or the distribution outsourcing pattern for health- care products and/or services and of general economic conditions such as changes in interest rates and the performance of the financial markets, changes in domestic and foreign laws, regulations and taxes, changes in competition and pricing environments, and general market and industry conditions. The forward-looking statements made in this press release are made in good faith as of the date of this release; Cardinal undertakes no obligation to publicly update or revise any forward-looking statements in this release.

SOURCE Cardinal Health, Inc.

CONTACT:
Investors, Stephen T. Fischbach, +1-614-757-7067, or Media, Geoffrey D. Fenton, +1-614-757-7871, both of Cardinal Health, Inc.